Explorer
Serum Institute Of India
News

SII's Covovax Covid Vaccine Now Available For Children In India, Says CEO Adar Poonawalla
Health

NTAGI Approves SII's Covovax Covid-19 Vaccine For Children Between 12-17 Age Group: Report
India

Covovax First Indian COVID Vaccine To Be Sold In Europe, Says SII's Adar Poonawalla
India

Covishield, Covaxin Prices Revised For Private Hospitals Day Before Booster Drive Begins — Check Rates
India

SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years
Health

Serum Institute Seeks EUA For Its Covovax Vaccine For 12-17 Years Age Group
India

Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population
India

Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval
News

SII Gets DCGI Nod To Manufacture Drug Substance, Test It For Developing Jab Against Omicron
India

CDSCO Panel Recommends Emergency Use Authorisation For SII's Covid vaccine Covovax
Health

Covovax Covid Vaccine Gets WHO Approval, Adar Poonawalla Calls It 'Another Milestone'
Health

Amid Omicron Fear, Expert Committee Gives No Recommendations For COVID Booster Dose: Report
Videos
India

Ground report from Hyderabad as PM Modi reaches Bharat Biotech
Short Videos
Advertisement
Advertisement
Advertisement
Top Headlines
Cities
Cities
India
Tamil Nadu
Advertisement
Trending News
